Official UK procurement notice
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
Authority: NHS England (Central government)
What is being bought
Published requirement descriptionNHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/25/5732
Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
CPV: Pharmaceutical products
How this framework works
From the published notice- Type
- Open framework
- Call-offs
- every call-off is a further competition among the appointed suppliers
- Bids received
- 11 bids received · 8 suppliers appointed
- Framework period
- 2 yrs · up to 4 yrs from 1 Mar 2026
Who may buy through it
Please refer to Document No. 09 in the ITO Document Set for the list of Participating Authorities/Purchasing Points.
Published description of the framework
Please refer to the ITO Documents for the Operation Description
The lotProcurement structure
single lot · value publishedLot #1AwardedRenewalPublished value£176,000,000
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- Price is not the only award criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents
- “NHS National Proprietary Pharmaceuticals - Low Molecular Weight…” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use the vehicle
- Please refer to Document No. 09 in the ITO Document Set for the list of Participating Authorities/Purchasing Points.
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 7 Aug 2025, 15:21 BST
- Last source update
- 18 Dec 2025, 11:34 GMT
- Award evaluation window
- Submission end – 4 Dec 2025
- Authority reference
C381280- FTS notice number
2025/S 000-057983- Latest notice
- Contract details notice (UK7)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-05838eFind a Tender
How it was run
Official notice- Appointment period ends
- 22 Oct 2025, 13:00 BST
- Clarification deadline
- 15 Oct 2025, 17:00 BST
- Submission channel
- Official e-sourcing portal
- Electronic submission
- Allowed
- Accepted languages
- en
The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗
Additional info obtained from the abovementioned address
Tenders must be submitted to the abovementioned address
Timeline
7 Aug 2025 → 1 Mar 2026 · 11 dates- Planning notice published7 Aug 2025, 15:21 BST
- Market engagement22 Aug 2025, 23:59 BST
NHS England is advising suppliers of an upcoming tender for the NHS National Framework Agreement for the supply of Low Molecular Weight Heparins and Fondaparinux to commence 1st March 2026 for 24 months with the option to extend for a further 24 months. The purpose of this notice is to inform existing and potential new suppliers that if NHS England believe that it would be beneficial a virtual 1:1 preliminary market meeting can be arranged. Please contact [email protected] to register your interest. There will also be a 7 day window for queries to be raised via Atamis after all sessions have concluded.
- Tender notice published391 days ago19 Sept 2025, 09:52 BST
- Next notice expected391 days ago19 Sept 2025, 23:59 BST
- Clarification questions by365 days ago15 Oct 2025, 17:00 BST
- Admission / appointment period ends358 days ago · period end, not a bid countdown22 Oct 2025, 13:00 BST
- Assessment summaries sent322 days ago28 Nov 2025
- Award decision expected by315 days ago4 Dec 2025, 23:59 GMT
- Standstill ends309 days ago10 Dec 2025, 23:59 GMT
- Latest notice published301 days ago18 Dec 2025, 11:34 GMT
- Contract starts229 days ago1 Mar 2026
Notice history
9 events · 4 releases on Find a Tender · since 7 Aug 2025- Preliminary market engagement notice published7 Aug 2025, 15:21 BSTUK2
- Tender notice published19 Sept 2025, 09:52 BSTUK4
- Status changed to active19 Sept 2025, 09:52 BST
- Procurement method changed19 Sept 2025, 09:52 BST
- Deadline published: 22 Oct 2025, 13:00 BST19 Sept 2025, 09:52 BST
- Contract award notice published28 Nov 2025, 12:41 GMTUK6
- Status changed to complete28 Nov 2025, 12:41 GMT
- Contract signature expected15 Dec 2025, 23:59 GMTscheduled
- Contract details notice published18 Dec 2025, 11:34 GMTUK7
Routine re-releases (4)
- 2025-08: 1 release · 7 Aug 2025
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| AVENTIS PHARMA LIMITED t-a Sanofi, Kent Pharma Ltd, NORTHUMBRIA PHARMA LTDSME, Pfizer Ltd, ROVI Biotech LimitedSME, Techdow Pharma England Ltd +2 moreNHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins1 Mar 2026 – 29 Feb 2028 · up to 28 Feb 2030Extensions: With an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. · Options: With an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. | £321,349,256 | 28 Nov 2025standstill to 10 Dec 2025 | Standstill |
Contracts
CM/PHR/25/5732 - Low Molecular Weight Heparins and Fondaparinux Products
- Signed
- 11 Dec 2025
- Value
- £321,349,256
- Period
- 1 Mar 2026 – 29 Feb 2028 · up to 28 Feb 2030 with extensions
- Status
- active
- Extensions
- With an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
- Options
- With an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 11final-stage tenders | 6 | 0 | — |
Who bid
- wonAventis Pharma ltd t/a Sanofi · South East England
- wonKent Pharma UK Limited · South East England
- wonNorthumbria Pharma LtdSME · North East England
- wonPfizer Limited · South East England
- wonRovi Biotech LimitedSME · Greater London
- wonTechdow Pharma England Limited · South East England
- wonViatris UK Healthcare Limited · East of England
- wonVenipharm LtdSME · Greater London
- did not winCST Pharma LimitedSME · West Midlands
- did not winDay Lewis Medical LimitedSME · Greater London
- did not winOrifarn UK LtdSME · East of England
Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.
Contracting authority & participating public bodies
Framework contractors & participating bidders
11 commercial parties on the notice · 8 awarded- Aventis Pharma Ltd t-a SanofiFramework contractor
- CST Pharma LimitedBidder / tenderer
- Day Lewis Medical LimitedBidder / tenderer
- Kent Pharma UK LimitedFramework contractor
- Northumbria Pharma LimitedFramework contractor
- Orifarn UK LtdBidder / tenderer
- Pfizer LtdFramework contractor
- ROVI Biotech LtdFramework contractor
- Techdow Pharma England LtdFramework contractor
- VENIPHARM LTDFramework contractor
- Viatris UK Healthcare LimitedFramework contractor
Official documents & specifications (19)
Official links; attachments are not copiedTender pack and attachments
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
Show 7 more documents
- Bidding documents and specifications
- Signed contract CONTRACT Document - CM-PHR-25-5723
- Signed contract Supplier Award Schedules (Redacted for Publication) - CM-PHR-25-5723
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
Notices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender